MeVis Medical Solutions AG (M3V)
XETRA Stock Exchange · Germany · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 21.60 |
|---|---|
| 52-week range | 21.40 – 26.80 |
| Return, 1 month / 3 months | −6.1% / −10.7% |
| Return, 1 year / 3 years | −10.3% / −9.0% |
| Trend | Below its 200-day average |
| RSI (14) | 26 |
| Volatility (1 year) | 21.6% |
| Worst drawdown (1 year) | -15.1% |
| Average daily value traded | 0.00M EUR |
| Dividend yield | 4.4% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
MeVis Medical Solutions AG develops software for medical image analysis and diagnostic imaging. Its products help radiologists and clinicians view and interpret scans of the breast, lungs and liver, and the company also supplies software components and development services to medical device makers and healthcare customers. The company is based in Bremen, Germany, and works with hospitals, imaging centres and equipment manufacturers that use its tools in clinical routine and research.
The shares are listed on the XETRA Stock Exchange in Germany under the code M3V, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
MeVis Medical Solutions AG (M3V) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 21.60 on 23 October 2026.
Its price-based Market X-Ray is 49 out of 100 (a weak price profile), ranking 405 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 10.3% and over the last three months it fell 10.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 46 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -8.1% | ||
| From 52-week high | -18.2% | ||
| Momentum | 38 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -10.7% | ||
| 6-month return | -5.3% | ||
| 12-month return, skipping the last month | -4.5% | ||
| Stability (higher is calmer) | 91 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 21.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -15.1% | ||
| Liquidity | 2 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.00M EUR | ||
| Zero-volume days | 70.0% | ||
| Income | 46 · Weak | Dividend is small or irregular. | |
| Dividend yield | 4.4% | ||
| Years with dividends | 4 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | +0.0% |
|---|---|
| 1 month | −6.1% |
| 3 months | −10.7% |
| 6 months | −5.3% |
| 1 year | −10.3% |
| 3 years | −9.0% |
| 5 years | −22.6% |
Signals
| 50-day / 200-day average | 23.03 / 23.52 |
|---|---|
| Golden / death cross (60 days) | Death, 19 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.17 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 20 Mar 2026 | EUR 0.9500 |
| 26 Mar 2025 | EUR 0.9500 |
| 20 Mar 2024 | EUR 0.9500 |
| 24 Mar 2022 | EUR 0.9500 |
| 25 Mar 2021 | EUR 0.9500 |
| 25 Jun 2020 | EUR 0.9500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.